Literature DB >> 32701124

The Importance of Locoregional Therapy in Metastatic Nasopharyngeal Cancer.

Nadeem Riaz1, Eric Sherman2, Nancy Lee1,3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32701124     DOI： 10.1001/jamaoncol.2020.1793

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma.

Authors:  Chwee Ming Lim; Anthony Liou; Michelle Poon; Liang Piu Koh; Lip Kun Tan; Kwok Seng Loh; Bengt Fredrik Petersson; Eric Ting; Dario Campana; Boon Cher Goh; Noriko Shimasaki
Journal:  Cancer Immunol Immunother       Date:  2022-01-30       Impact factor: 6.630

2.  Synchronous Metastatic Nasopharyngeal Carcinoma: Characteristics and Survival of Patients Adding Definitive Nasopharyngeal-Neck Radiotherapy to Systematic Chemotherapy.

Authors:  Wenjun Liao; Jinlan He; Qiheng Gou; Baofeng Duan; Lei Liu; Ping Ai; Yanchu Li; Kexing Ren; Nianyong Chen
Journal:  Cancer Manag Res       Date:  2020-10-15       Impact factor: 3.989

3.  Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States.

Authors:  Marwan Almoiliqy; Abdullah Al-Danakh; Mohammed Safi; Mohammed Alradhi; Mahmoud Al-Azab; Salah Adlat; Wanhai Zhou; Aiman Saleh A Mohammed; Ahmed Al-Maamari
Journal:  Oxid Med Cell Longev       Date:  2021-04-30       Impact factor: 6.543
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.